Thalassemia screening: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Thalassemia}} {{CMG}} ==Overview== ==Screening== A screening policy exists on both sides of the island of Cyprus to reduce the incidence of thalassemia, which ..." |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Thalassemia}} | {{Thalassemia}} | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
{{CMG}} | {{CMG}} | ||
| Line 16: | Line 18: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Needs content]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 20:54, 27 August 2012
|
Thalassemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Thalassemia screening On the Web |
|
American Roentgen Ray Society Images of Thalassemia screening |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Screening
A screening policy exists on both sides of the island of Cyprus to reduce the incidence of thalassemia, which since the program's implementation in the 1970s (which also includes pre-natal screening and abortion) has reduced the number of children born with the hereditary blood disease from 1 out of every 158 births to almost zero.[1]
References
- ↑ Leung NT, Lau TK, Chung TKH (2005). "Thalassemia screening in pregnancy". Curr Opinion in Ob Gyn. 17: 129&ndash, 34.